SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Empty drug store shelves in Phoenix, Arizona shortly after quarantine measures were announced. (Photo: Shutterstock)
I Take Hydroxychloroquine. Please Don't Hoard It.
To prevent hoarding and protect public health, we need to move towards universal care and lower-cost drugs.
Apr 15, 2020
The best birthday present I got this year was a refill of my medication. Ordinarily, that wouldn't be much to celebrate, but the coronavirus has upended the ordinary.
I've been taking hydroxychloroquine, an anti-malarial drug, since I was diagnosed with rheumatoid arthritis at 22. Thankfully, it's kept my disease from progressing. It's not an exaggeration to say it's the only reason I don't need a cane right now.
When I saw that chloroquine was being touted by President Trump and others as a potential treatment for the coronavirus, my heart sank. I counted the pills I had left and called my doctor.
Thankfully, I'm still getting my medication -- for now.
It isn't clear yet whether chloroquine is an effective treatment for COVID-19. There aren't any definitive studies to prove it -- in fact, a study in Brazil had to be halted over concerns about potentially fatal heart complications.
But that hasn't stopped some doctors from using it to treat their COVID-19 patients. Some hospitals are stockpiling the drug in advance, while some people who haven't tested positive -- and who don't need the drug for other medical reasons -- are trying to get their hands on a supply.
As a result, I'm not the only person worrying about getting access to this life-saving medication.
Thousands upon thousands of people around the world rely on it, both to treat rheumatoid arthritis and to control malaria outbreaks. Imagine what it's like for them watching otherwise healthy people try to stock up on this drug like they're rushing to scoop up toilet paper.
Due to high costs, people already ration much-needed medications even in the best of times. And now, in a crisis, drug companies are angling to capitalize on this pandemic.
Drug maker Gilead, for example, sought -- and received -- a monopoly from the FDA to produce a promising coronavirus treatment, which would have surely put it out of reach for millions. The company only backed down after intense public pressure.
Before the outbreak, drug manufacturer Rising Pharmaceuticals had decided to double the price of Plaquenil, the brand-name version of hydroxychloroquine, but the company temporarily suspended the price hike. How nice of them.
Still, with banks reportedly encouraging drug companies to price gouge at will -- and some U.S. senators more concerned with selling stock than protecting the public -- it feels very vulnerable to rely on a life-saving medication at a time like this.
Anyone needing treatment for this virus should get it. But that also means we need to protect others who rely on drugs like chloroquine from the hoarding and price gouging that could put our medications out of reach, too.
No one -- from coronavirus patients to people with conditions like mine -- should feel like they need to hoard drugs to feel safe, or be deprived of access to drugs they need to survive.
If you are generally healthy, there's something you can do to give people like me a fighting chance: Demand that Congress put people's health first in the next coronavirus stimulus package. Call on them to require insurers to eliminate patient costs associated with treating the disease.
And call on them to move toward universal health care and lower-cost prescription drugs for all ailments.
I am incredibly lucky. Many people with rheumatoid arthritis have far worse symptoms than I and were first diagnosed later in life, when they may have developed other complications. These are people who are particularly vulnerable to COVID-19.
We have already lost too many people to this pandemic, and we will lose more. It's more urgent than ever that we act to protect public health.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
This column was distributed by OtherWords.
The best birthday present I got this year was a refill of my medication. Ordinarily, that wouldn't be much to celebrate, but the coronavirus has upended the ordinary.
I've been taking hydroxychloroquine, an anti-malarial drug, since I was diagnosed with rheumatoid arthritis at 22. Thankfully, it's kept my disease from progressing. It's not an exaggeration to say it's the only reason I don't need a cane right now.
When I saw that chloroquine was being touted by President Trump and others as a potential treatment for the coronavirus, my heart sank. I counted the pills I had left and called my doctor.
Thankfully, I'm still getting my medication -- for now.
It isn't clear yet whether chloroquine is an effective treatment for COVID-19. There aren't any definitive studies to prove it -- in fact, a study in Brazil had to be halted over concerns about potentially fatal heart complications.
But that hasn't stopped some doctors from using it to treat their COVID-19 patients. Some hospitals are stockpiling the drug in advance, while some people who haven't tested positive -- and who don't need the drug for other medical reasons -- are trying to get their hands on a supply.
As a result, I'm not the only person worrying about getting access to this life-saving medication.
Thousands upon thousands of people around the world rely on it, both to treat rheumatoid arthritis and to control malaria outbreaks. Imagine what it's like for them watching otherwise healthy people try to stock up on this drug like they're rushing to scoop up toilet paper.
Due to high costs, people already ration much-needed medications even in the best of times. And now, in a crisis, drug companies are angling to capitalize on this pandemic.
Drug maker Gilead, for example, sought -- and received -- a monopoly from the FDA to produce a promising coronavirus treatment, which would have surely put it out of reach for millions. The company only backed down after intense public pressure.
Before the outbreak, drug manufacturer Rising Pharmaceuticals had decided to double the price of Plaquenil, the brand-name version of hydroxychloroquine, but the company temporarily suspended the price hike. How nice of them.
Still, with banks reportedly encouraging drug companies to price gouge at will -- and some U.S. senators more concerned with selling stock than protecting the public -- it feels very vulnerable to rely on a life-saving medication at a time like this.
Anyone needing treatment for this virus should get it. But that also means we need to protect others who rely on drugs like chloroquine from the hoarding and price gouging that could put our medications out of reach, too.
No one -- from coronavirus patients to people with conditions like mine -- should feel like they need to hoard drugs to feel safe, or be deprived of access to drugs they need to survive.
If you are generally healthy, there's something you can do to give people like me a fighting chance: Demand that Congress put people's health first in the next coronavirus stimulus package. Call on them to require insurers to eliminate patient costs associated with treating the disease.
And call on them to move toward universal health care and lower-cost prescription drugs for all ailments.
I am incredibly lucky. Many people with rheumatoid arthritis have far worse symptoms than I and were first diagnosed later in life, when they may have developed other complications. These are people who are particularly vulnerable to COVID-19.
We have already lost too many people to this pandemic, and we will lose more. It's more urgent than ever that we act to protect public health.
The best birthday present I got this year was a refill of my medication. Ordinarily, that wouldn't be much to celebrate, but the coronavirus has upended the ordinary.
I've been taking hydroxychloroquine, an anti-malarial drug, since I was diagnosed with rheumatoid arthritis at 22. Thankfully, it's kept my disease from progressing. It's not an exaggeration to say it's the only reason I don't need a cane right now.
When I saw that chloroquine was being touted by President Trump and others as a potential treatment for the coronavirus, my heart sank. I counted the pills I had left and called my doctor.
Thankfully, I'm still getting my medication -- for now.
It isn't clear yet whether chloroquine is an effective treatment for COVID-19. There aren't any definitive studies to prove it -- in fact, a study in Brazil had to be halted over concerns about potentially fatal heart complications.
But that hasn't stopped some doctors from using it to treat their COVID-19 patients. Some hospitals are stockpiling the drug in advance, while some people who haven't tested positive -- and who don't need the drug for other medical reasons -- are trying to get their hands on a supply.
As a result, I'm not the only person worrying about getting access to this life-saving medication.
Thousands upon thousands of people around the world rely on it, both to treat rheumatoid arthritis and to control malaria outbreaks. Imagine what it's like for them watching otherwise healthy people try to stock up on this drug like they're rushing to scoop up toilet paper.
Due to high costs, people already ration much-needed medications even in the best of times. And now, in a crisis, drug companies are angling to capitalize on this pandemic.
Drug maker Gilead, for example, sought -- and received -- a monopoly from the FDA to produce a promising coronavirus treatment, which would have surely put it out of reach for millions. The company only backed down after intense public pressure.
Before the outbreak, drug manufacturer Rising Pharmaceuticals had decided to double the price of Plaquenil, the brand-name version of hydroxychloroquine, but the company temporarily suspended the price hike. How nice of them.
Still, with banks reportedly encouraging drug companies to price gouge at will -- and some U.S. senators more concerned with selling stock than protecting the public -- it feels very vulnerable to rely on a life-saving medication at a time like this.
Anyone needing treatment for this virus should get it. But that also means we need to protect others who rely on drugs like chloroquine from the hoarding and price gouging that could put our medications out of reach, too.
No one -- from coronavirus patients to people with conditions like mine -- should feel like they need to hoard drugs to feel safe, or be deprived of access to drugs they need to survive.
If you are generally healthy, there's something you can do to give people like me a fighting chance: Demand that Congress put people's health first in the next coronavirus stimulus package. Call on them to require insurers to eliminate patient costs associated with treating the disease.
And call on them to move toward universal health care and lower-cost prescription drugs for all ailments.
I am incredibly lucky. Many people with rheumatoid arthritis have far worse symptoms than I and were first diagnosed later in life, when they may have developed other complications. These are people who are particularly vulnerable to COVID-19.
We have already lost too many people to this pandemic, and we will lose more. It's more urgent than ever that we act to protect public health.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.